Pacific Biosciences of California, Inc.
PACB
$1.13
$0.043.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.86% | 10.98% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.86% | 10.98% | |||
| Cost of Revenue | 17.13% | 22.49% | |||
| Gross Profit | -40.33% | -6.77% | |||
| SG&A Expenses | 52.10% | -3.99% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.99% | -3.70% | |||
| Operating Income | -59.58% | 12.01% | |||
| Income Before Tax | 104.42% | 64.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 103.90% | 64.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 103.90% | 64.96% | |||
| EBIT | -59.58% | 12.01% | |||
| EBITDA | -77.22% | 15.64% | |||
| EPS Basic | 103.78% | 65.03% | |||
| Normalized Basic EPS | -63.85% | 15.37% | |||
| EPS Diluted | 103.69% | 65.23% | |||
| Normalized Diluted EPS | -51.08% | 15.37% | |||
| Average Basic Shares Outstanding | 3.69% | 0.19% | |||
| Average Diluted Shares Outstanding | 12.45% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||